For brands and retailers, the message is clear: we are moving from raw-material competition to performance-driven delivery
The same angiogenesis that helps a damaged tendon can in theory help a tumor get a blood supply, which is why oncologists pay attention to this mechanism even though no study has shown BPC-157 causes cancer
Advanced glycation end products finally lead to arterial stiffness, diabetic nephropathy, and endothelial dysfunction
Zepbound Outperforms CagriSema in Head-to-Head Phase III Obesity Trial A pivotal Phase III trial has delivered a setback for Novo Nordisk, after its obesity candidate CagriSema was outperformed by Eli Lillys Zepbound (tirzepatide) in a direct comparison study
However, even in PTSD type symptoms, lab testing can fill an important diagnostic role
Outcomes differ: Approximately 70% of patients experienced significant weight loss after 6 months of semaglutide treatment